Magnetite nanoparticles (Fe3O4) have been loaded with different anticancer drugs including doxorubicin, daunorubicin, 5-bromotetrandrine [16], [17], [18], anti-HER2 immunoliposomes [19] and so on to evaluate their therapeutic potential in breast cancer. Here, ERBB2 is linked to breast carcinoma.